Gene · 5900
Papers1,907
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,907
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In the eye of the storm: impact of COVID-19 pandemic on admission patterns to paediatric intensive care units in the UK and Eire. | Crit Care | 2021 | 34789305 | PubTator, text mining | PubMed |
| CRISPR and KRAS: a match yet to be made. | J Biomed Sci | 2021 | 34781949 | PubTator, text mining | PubMed |
| KRAS mutation: from undruggable to druggable in cancer. | Signal Transduct Target Ther | 2021 | 34776511 | PubTator, text mining | PubMed |
| Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities. | Cancers (Basel) | 2021 | 34771644 | PubTator, text mining | PubMed |
| Integrative Bioinformatics approaches to therapeutic gene target selection in various cancers for Nitroglycerin. | Sci Rep | 2021 | 34764329 | PubTator, text mining | PubMed |
| Evaluation of Placentation and the Role of the Aryl Hydrocarbon Receptor Pathway in a Rat Model of Dioxin Exposure. | Environ Health Perspect | 2021 | 34747641 | PubTator, text mining | PubMed |
| Ral GEF with the PH Domain and SH3 Binding Motif 1 Regulated by Splicing Factor Junction Plakoglobin and Pyrimidine Metabolism Are Prognostic in Uterine Carcinosarcoma. | Dis Markers | 2021 | 34745385 | PubTator, text mining | PubMed |
| Polyphenols as Antitumor Agents Targeting Key Players in Cancer-Driving Signaling Pathways. | Front Pharmacol | 2021 | 34744708 | PubTator, text mining | PubMed |
| Engineering a cell-penetrating hyperstable antibody scFv(Ras) - An extraordinary approach to cancer therapeutics. | Synth Syst Biotechnol | 2021 | 34738045 | PubTator, text mining | PubMed |
| Determining oncogenic patterns and cancer predisposition through the transcriptomic profile in Mitchell-Riley syndrome with heterotopic gastric mucosa and duodenal atresia: a case report. | Orphanet J Rare Dis | 2021 | 34715892 | PubTator, text mining | PubMed |
| RAS Dimers: The Novice Couple at the RAS-ERK Pathway Ball. | Genes (Basel) | 2021 | 34680951 | PubTator, text mining | PubMed |
| Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers. | Cancers (Basel) | 2021 | 34680229 | PubTator, text mining | PubMed |
| Using Live-Cell Imaging and Synthetic Biology to Probe Directed Migration in Dictyostelium. | Front Cell Dev Biol | 2021 | 34676215 | PubTator, text mining | PubMed |
| K15 promoter-driven enforced expression of NKIRAS exhibits tumor suppressive activity against the development of DMBA/TPA-induced skin tumors. | Sci Rep | 2021 | 34667224 | PubTator, text mining | PubMed |
| Stress Granules Involved in Formation, Progression and Metastasis of Cancer: A Scoping Review. | Front Cell Dev Biol | 2021 | 34604242 | PubTator, text mining | PubMed |
| The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenon. | Transl Oncol | 2021 | 34592589 | PubTator, text mining | PubMed |
| LPHN2 inhibits vascular permeability by differential control of endothelial cell adhesion. | J Cell Biol | 2021 | 34581723 | PubTator, text mining | PubMed |
| Carbon Dioxide-Derived Biodegradable and Cationic Polycarbonates as a New siRNA Carrier for Gene Therapy in Pancreatic Cancer. | Nanomaterials (Basel) | 2021 | 34578632 | PubTator, text mining | PubMed |
| A Finite Element Study to Investigate the Mechanical Behaviour of Unidirectional Recycled Carbon Fibre/Glass Fibre-Reinforced Epoxy Composites. | Polymers (Basel) | 2021 | 34578093 | PubTator, text mining | PubMed |
| Anticancer and Structure Activity Relationship of Non-Symmetrical Choline Kinase Inhibitors. | Pharmaceutics | 2021 | 34575436 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5900/papers?page=16